PTC THERAPEUTICS, INC.

Pharmaceutical Preparations·WARREN, NJ·FY end 12/31·CIK 1070081

CEO Pay Ratio

7:1

Matthew B. Klein

CEO Total Comp

$23.3M

Matthew B. Klein

Median Employee

$245,742

Revenue

$1.7B

FY 2025

Net Income

$682.6M

FY 2025

Free Cash Flow

$702.3M

FY 2025

Net Margin

39.4%

Insider Net (180d)

-$10.7M

0 buys / 45 sales

CEO Pay Accountability

CEO comp as % of net income

3.41%

For every $1,000 of profit, $34.08 flows to the CEO.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$1.7B	$806.8M	$937.8M	$698.8M	$538.6M
Gross Profit	—	—	—	—	—	—
Operating Income	$866.9M	-$302.6M	-$439.5M	-$447.4M	-$374.4M
Net Income	$682.6M	-$363.3M	-$626.6M	-$559.0M	-$523.9M
Operating CF	$711.2M	-$107.7M	-$158.4M	-$356.7M	-$251.3M
Capex	$8.9M	$6.5M	$28.4M	$32.0M	$28.2M
Free Cash Flow	$702.3M	-$114.2M	-$186.9M	-$388.7M	-$279.5M
Buybacks	—	—	—	—	—	—
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	50.1%	-37.5%	-46.9%	-64.0%	-69.5%
Net Margin	39.4%	-45.0%	-66.8%	-80.0%	-97.3%
FCF Margin	40.6%	-14.2%	-19.9%	-55.6%	-51.9%
R&D / Revenue	26.3%	66.2%	71.1%	93.2%	100.4%
Effective Tax	2.0%	-0.0%	10.0%	4.8%	-1.1%
Debt / Equity	—	-0.26	-0.35	-1.65	196.03
Buybacks / FCF	—	—	—	—	—	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Matthew B. KleinChief Executive Officer	$958.5K	$16.6M	$4.4M	$1.3M	$20.3K	$23.3M
Eric PauwelsChief Business Officer	$613.1K	$1.0M	$1.4M	$517.8K	$25.4K	$3.6M
Pierre GravierChief Financial Officer	$579.2K	$1.0M	$1.4M	$488.6K	$21.7K	$3.6M
Lee GoldenExecutive Vice President and Chief Medical Officer	$574.7K	$930.8K	$1.3M	$482.8K	$23.8K	$3.3M
Neil AlmsteadChief Technical Operations Officer	$582.5K	$884.3K	$1.2M	$467.4K	$30.7K	$3.2M